HIV infection and aging: Mechanisms to explain the accelerated rate of progression in the older patient

Mechanisms of Ageing and Development

Volumn 96, Issue 1-3, 1997, Pages 137-155

  Adler, William H ^a   Baskar, Padmavathi V ^a   Chrest, Francis J ^a   Dorsey Cooper, Barbara ^a   Winchurch, Richard A ^b   Nagel, James E ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Human aging; Human immunodeficiency virus 1; T lymphocyte

Indexed keywords

ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; AGING; ARTICLE; BACTERIAL INFECTION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AGING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE COUNT; MIDDLE AGED; SURVIVAL RATE; T-LYMPHOCYTES; TIME FACTORS;

EID: 0030915010     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(97)01888-5     Document Type: Article

References (165)

1. J.A. Ship, A. Wolff and R.M. Selik, Epidemiology of acquired immune deficiency syndrome in persons aged 50 years and older. J. Acquired Immune Defic. Syndr., 4 (1991) 84-88.
2. C. Ibegbu, T.J. Spira, S. Nesheim et al., Subpopulations of T and B cells in perinatally HIV-infected and non infected age-matched children compared with those in adults. Clin. Immunol. Immunopathol., 71 (1994) 27-32.
3. M.E. Eyster, M.H. Gail, J.O. Ballard, H. Al-Mondhiry and J.J. Goedert, Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts and age. Ann. Intern. Med., 107 (1987) 1-6.
4. T.A Peterman, R.L. Stoneburner, J.R. Allen, H.W. Jaffe and J.W. Curran, Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA, 259 (1988) 55-58.
5. S.C. Darby, C.R. Rizza, R. Doll, R.J. Spooner, I.M. Stratton and B. Thakrar, Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. Br. Med. J., 298 (1989) 1064-1068.
6. J.J. Goedert, C.M. Kessler, L.M. Aledort et al., A prospective study of human immuno deficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N. Engl. J. Med., 321 (1989) 1141-1148.
7. P.R. Becherer, M.L. Smiley, T.J. Matthews, K.J. Weinhold, C.W. McMillan and G.C. White, Human immunodeficiency virus-1 disease progression in hemophiliacs. Am. J. Hematol., 34 (1990) 204-209.
8. A. Blaxhult, F. Granath, K. Lidman and J. Giesecke, The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS, 4 (1990) 125-129.
9. E. Donegan, M. Stuart, J.C. Niland et al., Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann. Intern. Med., 113 (1990) 733-739.
10. M.A. Fletcher, J.W. Mosley, J. Hassett et al., Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Blood, 80 (1992) 831-840.
11. S.C. Darby, R. Doll, B. Thakrar, C.R. Rizza and D.R. Cox, Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat. Med., 9 (1990) 681-689.
12. P.S. Rosenberg, J.J. Goedert and R.J. Biggar, Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters. AIDS. 8 (1994) 803-810.
13. N. Schinaia, A.M. Ghirardini, M.G. Mazzucconi, G. Tagariello, M. Morfini and F. Chiarotti, Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite. Thromb. Haemost., 72 (1994) 33-38.
14. L.S. Diamondstone, S.A. Blakley, J.C. Rice, R.A. Clark and J.J. Goedert, Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus. Am. J. Epidemiol., 142 (1995) 304-313.
15. S.C. Darby, D.W. Ewart, P.L.F. Giangrande, R.J.D. Spooner and C.R. Rizza, Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet, 347 (1996) 1573-1579.
16. P. Bachetti, D. Osmond, R.E. Chaisson et al., Survival patterns of the first 500 patients with AIDS in San Francisco. J. Infect. Dis., 157 (1988) 1044-1047.
17. R. Rothenberg, M. Woelfel, R. Stoneburner, J. Milberg, R. Parker and B. Truman, Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N. Engl. J. Med., 317 (1987) 1297-1302.
18. A.R. Moss, P. Bacchetti, D. Osmond et al., Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br. Med. J. (Clin. Res.), 296 (1988) 745-750.
19. G.F. Lemp, S.F. Payne, D. Neal, T. Temelso and G.W. Rutherford, Survival trends for patients with AIDS. JAMA, 263 (1990) 402-406.
20. + T-cell counts. J. Acquired Immune Defic. Syndr., 4 (1991) 970-975.
21. S. Ferro and I.E. Salit, HIV infection in patients over 55 years of age. J. Acquired Immune Defic. Syndr., 5 (1992) 348-355.
22. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J. Infect. Dis., 165 (1992) 352-363.
23. I.P. Keet, P. Krijnen, M. Koot et al., Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS, 7 (1993) 51-57.
24. E. Kopec-Schrader, B. Tindall, J. Learmont, B. Wylie and J.M. Kaldor, Development of AIDS in people with transfusion-acquired HIV infection. AIDS, 7 (1993) 1009-1013.
25. N. Carre, C. Deveau, F. Belanger et al., Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. AIDS, 8 (1994) 797-802.
26. 6/1 but free of AIDS-defining clinical disease. AIDS, 8 (1994) 1577-1583.
27. P.J. Veugelers, S.A. Strathdee, B. Tindall et al., Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS, 8 (1994) 1471-1475.
28. P.J. Veugelers, K.A. Page, B. Tindall et al., Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am. J. Epidemiol. 140 (1994) 747-758.
29. + lymphocyte count <50/microL. J. Infect. Dis., 171 (1995) 829-836.
30. S.P. Blatt, W.F. McCarthy, B. Bucko-Krasnicka et al., Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J. Infect. Dis., 171 (1995) 837-844.
31. M. Tumbarello, E. Tacconelli, R. Cauda and L. Ortona, Age as a prognostic factor in AIDS. Lancet, 348 (1996) 623-627.
32. I.D. Gardner, The effect of aging on susceptibilty to infection. Rev. Infect. Dis., 2 (1980) 801-810.
33. W.P. Glezen, M. Decker and D.M. Perrotta, Survey of underlying conditions of persons hospitialized with acute respiratory disease during influenza epidemics in Houston 1978-1981. Am. Rev. Respir. Dis., 136 (1987) 550-555.
34. R. Heffron, Pneumonia, Harvard University Press, Cambridge, MA, 1939, pp. 304-308, 707-710.
35. Powers DC, Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age. J. Am. Geriatr. Soc., 41 (1993) 1-5.
36. Y. Cao, L. Qin, L. Zhang, J. Safrit and D.D. Ho, Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med., 332 (1995) 201-208.
37. D.D. Ho, A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard and M. Markowitz, Rapid turnover of plasma virons and CD4 lymphocytes in HIV-1. Nature, 373 (1995) 123-126.
38. X. Wei, S.K. Ghosh, M.E. Taylor et al., Viral dynamics in human immunodeficiency virus type 1 infection. Nature, 373 (1995) 117-122.
39. D.D. Ho, Viral counts count in HIV infection. Science, 272 (1996) 1124-1125.
40. + cell counts, and HIV-1 production by cells. Science, 271 (1996) 670-671.
41. A.T. Haase, K. Henry, M. Zupancic et al., Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science, 274 (1996) 985-989.
42. J.W. Mellors, C.R. Rinaldo, Jr., P. Gupta, R.M. White, J.A. Todd and L.A. Kingsley, Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science, 272 (1996) 1167-1170.
43. M.S. Saag, M. Holodniy, D.R. Kuritzkes et al., HIV viral load markers in clinical practice. Nat. Med., 2 (1996) 625-629.
44. J. Embretson, M. Zupancic, J.L. Ribas et al., Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature, 362 (1993) 359-362.
45. G. Pantaleo, C. Graziosi, J.F. Demarest et al., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature, 362 (1993) 355-358.
46. G. Pantaleo, A. De Maria, S. Koenig et al., CD8 + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc. Natl. Acad. Sci. USA, 87 (1990) 4818-4822.
47. C.R. Rinaldo, Jr., L.A. Beltz, X.L. Huang, P. Gupta, Z. Fan and D.J. Torpey 3rd, Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res. Hum. Retroviruses, 11 (1995) 481-489.
48. G. Pantaleo and A.S. Fauci, New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol., 13 (1995) 487-512.
49. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science, 234 (1986) 1563-1566.
50. + T cells. Evidence for a soluble inhibitor. J. Immunol., 144 (1990) 2961-2966.
51. + cells involves a noncytotoxic mechanism. J. Virol., 65 (1991) 5921-5927.
52. T. Harrer, E. Harrer, S.A. Kalams et al., Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses, 12 (1996) 585-592.
53. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc. Natl Acad Sci. USA, 87 (1990) 4818-4822.
54. S. Zanussi, M. D'Andrea, C. Simonelli, U. Tirelli and P. DePaoli, Serum levels of RANTES and MIP-1α in HIV-positive long-term survivors and progressor patients. AIDS, 10 (1996) 1431-1432.
55. + T cells. Science, 270 (1995) 1811-1815.
56. R.A. Weiss and P.R. Clapham, Hot fusion of HIV. Nature, 381 (1996) 647-648.
57. + T cells. Immunol. Today, 17 (1996) 217-224.
58. P.J. Maddon, A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss and R. Axel, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell, 47 (1986) 333-348.
59. P.R. Clapham, D. Blanc and R.A. Weiss, Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology, 181 (1991) 703-715.
60. P.A. Ashorn, E.A. Berger and B. Moss, Human immunodeficiency virus envelope glycoprotein/ CD4-mediated fusion of nonprimate cells with human cells. J. Virol., 64 (1990) 2149-2156.
61. T. Dragic and M. Alizon, Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2. J. Virol., 67 (1993) 2355-2359.
62. T. Dragic, P. Charneau, F. Clavel and M. Alizon, Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J. Virol., 66 (1992) 4794-4802.
63. D. Ramarli, C. Cambiaggi, C. De Giuli Morghen et al., Susceptibility of human-mouse T cell hybrids to HIV-productive infection. AIDS Res. Hum. Retroviruses, 9 (1993) 1269-1275.
64. D.B. Weiner, K. Huebner, W.V. Williams and M.I. Greene, Human genes other than CD4 facilitate HIV-1 infection of murine cells. Pathobiology, 59 (1991) 361-371.
65. M. Tersmette, J.J. van Dongen, P.R. Clapham et al., Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology, 168 (1989) 267-273.
66. Y. Feng, C.C. Broder, P.E. Kennedy and E.A. Berger, HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science, 272 (1996) 872-877.
67. H.K. Deng, R. Liu, W. Ellmeier et al., Identification of a major co-receptor for primary isolates of HIV-1. Nature, 381 (1996) 661-666.
68. G. Alkhatib, C. Combadiere, C.C. Broder et al., CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-trophic HIV-1. Science, 272 (1996) 1955-1958.
69. + cells is mediated by the chemokine receptor CC-CKR-5. Nature, 381 (1996) 667-673.
70. C.C. Bleul, M. Farzan, H. Choe et al., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382 (1996) 829-833.
71. K.B. Bacon, B.A. Premack, P. Gardner and T.J. Schall, Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269 (1995) 1727-1730.
72. E. Oberlin, A. Amara, F. Bachelerie et al., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature, 382 (1996) 833-835.
73. R. Liu, W.A. Paxton, S. Choe et al., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86 (1996) 367-377.
74. M. Dean, M. Carrington, C. Winkler et al., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273 (1996) 1856-1862.
75. M. Samson, F. Libert, B.J. Doranz et al., Resistance to HIV-I infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382 (1996) 722-725.
76. W.A. Paxton, S.R. Martin, D. Tse et al., Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med., 2 (1996) 412-417.
77. + T-cell clones. AIDS, 10 (1996) 1317-1321.
78. + T-cell-mediated suppression of HIV-1 infection may not be due to chemokines RANTES, MIP-1α and MIP-1β. AIDS, 10 (1996) 1434-1435.
79. M. Clerici, C. Balotta, D. Trabattoni et al., Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS, 10 (1996) 1432-1433.
80. + lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin. Exp. Immunol., 105 (1996) 220-224.
81. V. Blazevic, M. Heino, A. Ranki, T. Jussila and K.J.E. Krohn, RANTES, MIP and interleukin-16 in HIV infection. AIDS, 10 (1996) 1435-1436.
82. M. Baier, A. Werner, N. Bannert, K. Metzner and R. Kurth, HIV suppression by interleukin-16, Nature, 378 (1995) 563.
83. J.W. Maciaszek, N.A. Parada, W.W. Cruikshank, D.M. Center, H. Kornfeld and G.A. Viglianti, IL-16 represses HIV-1 promotor activity. J. Immunol., 158 (1997) 5-8.
84. H.C. Lane, H. Masur, E.P. Gelmann et al., Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am. J. Med., 78 (1985) 417-422.
85. H.E. Prince, V. Kermani-Arab and J.L. Fahey, Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J. Immunol., 133 (1984) 1313-1317.
86. H.E. Prince and J.K. John, Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders. Diagn. Immunol., 4 (1986) 306-311.
87. H.E. Prince and J.K. John, Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders. Clin. Exp. Immunol., 67 (1987) 59-65.
88. H.E. Prince, S. Kleinman and A.E. Williams, Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J. Immunol., 140 (1988) 1139-1141.
89. H.E. Prince and C.D. Czaplicki, In vitro activation of T lymphocytes from HIV-seropositive blood donors. II. Decreased mitogen-induced expression of interleukin 2 receptor by both CD4 and CD8 cell subsets. Clin. Immunol. Immunopathol., 48 (1988) 132-139.
90. C.G. Munn, J.M. Reuben, E.M. Hersh, P.W. Mansell and G.R. Newell, T cell surface antigen expression on lymphocytes of patients with AIDS during in vitro mitogen stimulation. Cancer Immunol. Immunother., 18 (1984) 141-148.
91. E.C. Ebert, D.B. Stoll, B.J. Casseus, W.H. Lipshutz and S.P. Hauptman, Diminished interleukin 2 production and receptor generation characterize the acquired immunodeficiency syndrome. Clin. Immunol. Immunopathol., 37 (1985) 282-297.
92. S. Gupta, Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Clin. Immunol. Immunopathol., 38 (1986) 93-100.
93. H.E. Prince, S.H. Kleinman, V.C. Maino and A.L. Jackson, In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis. J. Clin. Immunol., 8 (1988) 114-120.
94. K.K. Sethi and H. Naher, Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immuno deficiency syndrome. Immunol. Lett., 13 (1986) 179-184.
95. M. Ciardi, M.K. Sharief, M.A. Noori et al., Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies. J. Neurol. Sci., 115 (1993) 117-122.
96. J.C. Fackler, J.E. Nagel, W.H. Adler, P.T. Mildvan and R.F. Ambinder, Epstein-Barr virus infection in a child with acquired immunodeficiency syndrome. Am. J. Dis. Child., 139 (1985) 1000-1004.
97. N.E. Kendig, F.J. Chrest, J.E. Nagel, R.E. Chaisson, A.J. Saah and W.H. Adler, Age-related changes in the immune function of HIV-1 seropositive adults. Aging Immunol. Infect. Dis., 3 (1991) 67-80.
98. J.B. Margolick, D.J. Volkman, T.M. Folks and A.S. Fauci, Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J. Immunol., 138 (1987) 1719-1723.
99. A. Winkelstein, L.A. Kingsley, L.D. Weaver and L.L. Machen, Defective T cell colony formation and IL-2 receptor expression in HIV-infected homosexuals: relationship between functional abnormalities and CD4 cell numbers. J. Acquired Immune Defic. Syndr., 2 (1989) 353-358.
100. M.B. Feinberg, Changing the natural history of HIV disease. Lancet, 348 (1996) 239-246.
101. A.S. Fauci, Host factors and the pathogenesis of HIV-induced disease. Nature, 384 (1996) 529-534.
102. S.M. Schnittman, H.C. Lane, J. Greenhouse, J.S. Justement, M. Baseler and A.S. Fauci, Preferential infection of CD4+ memory T cells by human immuno deficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA, 87 (1990) 6058-6062.
103. C.J. van Noesel, R.A. Gruters, F.G. Terpstra, P.T. Schellekens, R.A. van Lier and F. Miedema, Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest., 86 (1990) 293-299.
104. S. Rowland-Jones and A. McMichael, Cytotoxic T lymphocytes in HIV infection. Semin. Virol., 4 (1993) 83-94.
105. S. Rowland-Jones, J. Sutton, K. Ariyoshi et al., HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med., 1 (1995) 59-64.
106. M.A. Nowak, R.M. May, R.E. Phillips et al., Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature, 375 (1995) 606-611.
107. C. Enger, N. Graham, Y. Peng et al., Survival from early, intermediate, and late stages of HIV infection. JAMA, 275 (1996) 1329-1334.
108. J.W. Mellors, L.A. Kingsley, C.R. Rinaldo, Jr. et al., Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med., 122 (1995) 573-579.
109. H.W. Sheppard, W. Lang, M.S. Ascher, E. Vittinghoff and W. Winkelstein, The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS, 7 (1993) 1159-1166.
110. G. Pantaleo, S. Menzo, M. Vaccarezza et al., Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med., 332 (1996) 209-216.
111. C. Broström, A. Sönnerborg, S. Kim and M. Sällberg, Site-directed serology of HIV-1 subtype B infection: relation between virus specific antibody levels and disease progression. Clin. Exp. Immunol., 106 (1996) 35-39.
112. M.L. Gougeon, H. Lecoeur, A. Dulioust et al., Programmed cell death in peripheral lymphocytes from HIV-infected persons. Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and disease progression. J. Immunol., 156 (1996) 3509-3520.
113. J.C. Ameisen and A. Capron, Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today, 12 (1991) 102-105.
114. N.K. Banda, J. Bernier, D.K. Kurahara et al., Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med., 176 (1992) 1099-1106.
115. A.D. Badley, J.A. McElhinny, P.J. Leibson, D.H. Lynch, M.R. Alderson and C.V. Paya, Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol., 70 (1996) 199-206.
116. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today, 14 (1993) 107-111.
117. G. Pantaleo, C. Graziosi and A.S. Fauci, Mechanisms of disease: the immuno pathogenesis of human immunodeficiency virus infection. N. Engl. J. Med., 328 (1993) 327-335.
118. A. Muñoz, A.J. Kirby, Y.D. He et al., Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. J. Acquired Immune. Defic. Syndr. Hum. Retrovirol., 8 (1995) 496-505.
119. C. Rinaldo, X.L. Huang, Z.F. Fan et al., High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol., 69 (1995) 5838-5842.
120. W.J. Livingstone, M. Moore, D. Innes et al., Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Lancet, 348 (1996) 649-654.
121. M. Pope, M.G.H. Betjes, N. Romani et al., Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell, 78 (1994) 389-398.
122. T.R. O'Brien, W.A. Blattner, D. Waters et al., Serum, HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA, 276 (1996), 105-110.
123. + and declining CD3-populations suggest regulatory responses linked to loss of CD4 lymphocytes. J. Acquired Immune Defic. Syndr., 6 (1993) 153-161.
124. J.B. Margolick, A. Muñoz, A.D. Donnenberg et al., Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nat. Med., 7 (1995) 674-680.
125. L.M. Adleman and D. Wofsy, T-cell homeostasis: implications in HIV infection. J. Acquired Immune Defic. Syndr., 6 (1993) 144-152.
126. L.M. Adleman and D. Wofsy, Blind T-cell homeostasis in CD4-deficient mice. J. Acquired Immune Defic. Syndr. Hum. Retrovirol., 11 (1996) 334-340.
127. N. Galai, A. Muñoz, K. Chen, V.J. Carey, J. Chmiel and S.Y. Zhou, Tracking of markers and onset of disease among HIV-1 seroconverters. Stat. Med., 12 (1993) 2133-2145.
128. W. Lang, H. Perkins, R.E. Anderson, R. Royce, N. Jewell and W. Winkelstein, Jr., Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J. Acquired Immune Defic. Syndr., 2 (1989) 63-69.
129. D.R. Hoover, A. Saah, H. Bacellar et al., The progression of untreated HIV-1 infection prior to AIDS. Am. J. Public Health, 82 (1992) 153 815-153 841.
130. A.N. Phillips, C.A. Sabin, J. Elford, M. Bofill, C.A. Lee and G. Janossy, CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS, 7 (1993) 975-980.
131. + cells in HIV-1-infected patients. AIDS, 10 (1996) 827-834.
132. - T cell population. J. Immunol., 144 (1990) 1696-1704.
133. + T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. J. Acquired Immune Defic. Syndr., 6 (1993) 904-912.
134. C. E. Mackewicz, H.W. Ortega and J.A. Levy, CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest., 87 (1991) 1462-1466.
135. A. L. Landay, C.E. Mackewicz and J.A. Levy, An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol., 69 (1993) 106-116.
136. H.E. Prince and E.R. Jensen, Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. J. Acquired Immune Defic. Syndr., 4 (1991) 1227-1232.
137. H.Z. Bass, W.D. Hardy, R.T. Mitsuyasu, Y.X. Wang, W. Cumberland and J.L. Fahey, Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J. Acquired Immune Defic. Syndr., 5 (1992) 890-897.
138. + cells in human immunodeficiency virus type-1 infection. Clin. Immunol. Immunopathol., 63 (1992) 126-134.
139. + T lymphocytes during HIV-1 infection. Clin. Exp. Immunol., 95 (1994) 436-141.
140. M. Piatak, M.S. Saag, L.C. Yang et al., High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science, 259 (1993) 1749-1754.
141. C. Graziosi, G. Pantaleo, L. Butini et al., Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA, 90 (1993) 6405-6409.
142. A.D. Kelleher, A. Carr, J. Zaunders and D.A. Cooper, Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis., 173 (1996) 321-329.
143. S.A. Danner, A. Carr, J.M. Leonard et al., A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N. Engl. J. Med., 333 (1995) 1528-1533.
144. M. Levacher, S. Tallet, M.C. Dazza, E. Dournon, B. Rouveix and J.J. Pocidalo, T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS. Clin. Exp. Immunol., 81 (1990) 177-182.
145. M. Markowitz, M. Saag, W.G. Powderly et al., A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N. Engl. J. Med., 333 (1995) 1534-1539.
146. D.E. Mosier, CD4+ cell turnover. Nature (Letter), 375 (1995) 193-194.
147. M. Bukrinsky, K. Manogue and A. Cerami, Other approaches. Nature (Letter), 375 (1995) 195-196.
148. M.S. Ascher, H.W. Sheppard, R.W. Anderson, J.F. Krowka and H.J. Bremermann, Paradox remains. Nature (Letter), 375 (1995) 196.
149. A.S. Perelson, A.U. Neumann, M. Markowitz, J.M. Leonard and D.D. Ho, HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science, 271 (1996) 1582-1586.
150. J.E. Nagel, F.J. Chrest, P. Lal and W.H. Adler, Immune function, cell death, and aging. In N.J. Holbrook, G.R. Martin and R.A. Lockshin (eds.), Cellular Aging and Cell Death, Wiley, New York, 1996, pp. 51-65.
151. M.A. Phelouzat, A. Arbogast, T. Laforge, R.A. Quadri and J.J. Proust, Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech. Ageing Dev., 88 (1996) 25-38.
152. C. Caruso, G. Candore, D. Cigna et al., Cytokine production pathway in the elderly. Immunol. Res., 15 (1996) 84-90.
153. D.R. Jackola, J.K. Ruger and R.A. Miller, Age-associated changes in human T cell phenotype and function. Aging (Milano) 9 (1994) 25-34.
154. C.R. Engwerda, B.S. Fox and B.S. Handwerger, Cytokine production by T lymphocytes from young and aged mice. J. Immunol., 156 (1996) 3621-3630.
155. W.H. Adler and J.E. Nagel, Clinical immunology and aging. In W.R. Hazzard, E.L. Bierman, J.P. Blass, W.H. Ettinger, Jr., J.B. Halter and R. Andres (eds.), Principles of Geriatric Medicine and Gerontology, 3rd edn, McGraw-Hill, New York, 1994, pp 61-75.
156. 2 subsets: paradigms lost? Immunol. Today, 16 (1995) 374-379.
157. H2 predominance in HIV-infected individuals. Science, 265 (1994) 248-252.
158. H0 cells. Science, 265 (1994) 244-248.
159. + cell response against human immunodeficiency virus: Implications for long-term survival. Proc. Natl. Acad. Sci. USA, 92 (1995) 11 135-11 139.
160. J. Yoo, H. Chen, T. Kraus et al., Altered cytokine production and accessory cell function after HIV-1 infection. J. Immunol., 157 (1996) 1313-1320.
161. D.S. Stein, J.G. Timpone, J.D. Gradon, J.M. Kagan and S.M. Schnittman, Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual. Clin. Infect. Dis., 17 (1993) 749-771.
162. J.A. Kovacs, S. Vogel, J.M. Albert et al., Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med., 335 (1996) 1350-1356.
163. + T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med., 332 (1995) 143-149.
164. S. Shahabuddin, Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets. J. Clin. Lab. Immunol., 36 (1991) 27-32.
165. P.A. Volberding, Age as a predictor of progression in HIV infection. Lancet, 347 (1996) 1569-1570.